$1.33
7.72% today
Nasdaq, Apr 02, 09:20 pm CET
ISIN
US31447E1055
Symbol
FEMY

Femasys Inc Stock price

$1.23
-0.31 20.13% 1M
+0.11 9.82% 6M
+0.13 11.82% YTD
-0.49 28.49% 1Y
-0.89 41.98% 3Y
-10.77 89.75% 5Y
-10.77 89.75% 10Y
Nasdaq, Closing price Tue, Apr 01 2025
-0.02 1.60%
ISIN
US31447E1055
Symbol
FEMY
Sector

Key metrics

Market capitalization $28.17m
Enterprise Value $32.16m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 19.73
P/S ratio (TTM) P/S ratio 17.28
P/B ratio (TTM) P/B ratio 12.47
Revenue growth (TTM) Revenue growth 51.97%
Revenue (TTM) Revenue $1.63m
EBIT (operating result TTM) EBIT $-17.79m
Free Cash Flow (TTM) Free Cash Flow $-20.21m
Cash position $3.45m
EPS (TTM) EPS $-0.84
P/E forward negative
P/S forward 3.00
EV/Sales forward 3.42
Short interest 6.32%
Show more

Is Femasys Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Femasys Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Femasys Inc forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Femasys Inc forecast:

Buy
100%

Financial data from Femasys Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1.63 1.63
52% 52%
100%
- Direct Costs 1.42 1.42
10% 10%
87%
0.21 0.21
195% 195%
13%
- Selling and Administrative Expenses 8.91 8.91
44% 44%
547%
- Research and Development Expense 8.22 8.22
14% 14%
504%
-17 -17
24% 24%
-1,037%
- Depreciation and Amortization 0.87 0.87
4% 4%
53%
EBIT (Operating Income) EBIT -18 -18
23% 23%
-1,091%
Net Profit -19 -19
32% 32%
-1,155%

In millions USD.

Don't miss a Thing! We will send you all news about Femasys Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Femasys Inc Stock News

Neutral
GlobeNewsWire
6 days ago
-- Company expands commercial product offering with FemBloc ® permanent birth control (delivery system) approval in Europe and signed partnerships for distribution in Spain -- ATLANTA, March 27, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-...
Neutral
GlobeNewsWire
14 days ago
Femasys continues to expand access and market share for its first-line infertility treatment option Femasys continues to expand access and market share for its first-line infertility treatment option
Neutral
GlobeNewsWire
15 days ago
-- Company taps first EU distributors, Comercial Medico Quirurigca, SA and Durgalab, as the first globally to be granted rights to commercialize FemBloc® -- ATLANTA, March 18, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic...
More Femasys Inc News

Company Profile

Femasys, Inc. operates as a medical device company that focuses on women's healthcare. Its products include FemVue Saline-Air Device, which creates and delivers an alternating pattern of saline and air as a continuous stream, and enables physicians to assess their patients fallopian tubes, and FemChec Pressure Management Device, which limits the maximum applied pressure while performing hysterosalpingogram. The firm offers FemCerv, an endocervical curettage device to collect a non-contaminated tissue sample for cervical cancer screening. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.

Head office United States
CEO Kathy Lee-Sepsick
Employees 71
Founded 2004
Website www.femasys.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today